Announced Wed, 24 Jun · 18:36 IST
Trading window closed ahead of Q1 FY26 results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.8%1-day move
₹50.90
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.8-1.3-1.8-3.7-2.5+0.7-1.9-3.4——
Up moveDown movePending
AI summary
Eiko Lifesciences has closed its trading window from July 1, 2026 until 48 hours after the board meeting that will consider un-audited standalone and consolidated financial results for Q1 FY26 (quarter ended June 30, 2026). The board meeting date will be announced separately. All designated persons and their immediate relatives are barred from trading in company securities during this period. This is a routine compliance measure under SEBI Insider Trading Regulations.
Likely market impact
Routine SEBI compliance ahead of quarterly results. No direct price impact, but signals that Q1 FY26 earnings announcement is coming soon.